HSE pays 47% more for 'brand name' drugs

A new survey has found that Ireland's Health Service is paying one-and-a-half times more than Britain for brand name medicines.

The study carried out for the Swedish pharmaceutical sector shows that Ireland pays more than any other Northern European country for drugs that are still under patent.

The survey found that the HSE pays 47% more than Britain's NHS for such "brand name" drugs.

Email Updates

Receive our lunchtime briefing straight to your inbox

More in this Section

Dundalk man sues Facebook in 'biggest drug dealer' defamation claim

Two remain in hospital following Clare cattle mart incident

Ex-GAA player Brian Nolan gets €310,000 damages over swinger parties articles

Body of woman found in west Cork


Today's Stories

‘This was the worst example of driving I have ever seen’

Security men burst in on couple in state of undress

Cyclist died after crashing into parked jeep

Simon Coveney stages comeback

Lifestyle

My life in colour - Anne Madden on artistic success and a life in France and Ireland

Ask Audrey - 'There is no such thing as a Kerry man with only small amounts of perspiration'

DNA testing to determine your family history can provide some surprising results

Stay protected this summer with the latest sunscreens

More From The Irish Examiner